Mark Baldry, Chief Commercial Officer at X4 Pharmaceuticals ($XFOR), made one open market purchase of company shares in the last year, totaling $2,561 on May 16, 2025. This ranks him 4,715th among 4,983 insiders by purchase value, well below the average of $1.46 million across 3.3 transactions. Baldry reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | X4 Pharmaceuticals, Inc | $XFOR | Baldry Mark | Chief Commercial Officer | A | Common Stock | 1032 | $2.48 | 25,337.0000 | 201,062,211 | 4.25% | 0.00% |
| May 16, 2025 | X4 Pharmaceuticals, Inc | $XFOR | Baldry Mark | Chief Commercial Officer | P | Common Stock | 1032 | $2.48 | 25,337.0000 | 201,062,211 | 4.25% | 0.00% |
| Nov. 15, 2024 | X4 Pharmaceuticals, Inc | $XFOR | Baldry Mark | Chief Commercial Officer | P | Common Stock | 13404 | $0.34 | 129,173.0000 | 6,695,509 | 11.58% | 0.20% |
| Feb. 12, 2025 | X4 Pharmaceuticals, Inc | $XFOR | Baldry Mark | Chief Commercial Officer | A | Common Stock | 600000 | $0.00 | 729,173.0000 | 201,062,211 | 464.49% | 0.30% |
| May 17, 2024 | X4 Pharmaceuticals, Inc | $XFOR | Baldry Mark | Chief Commercial Officer | P | Common Stock | 21646 | $0.68 | 115,769.0000 | 177,812,480 | 23.00% | 0.01% |
| Jan. 23, 2025 | X4 Pharmaceuticals, Inc | $XFOR | Baldry Mark | Chief Commercial Officer | A | Common Stock | 74773 | $0.00 | 123,282.0000 | 201,062,211 | 154.14% | 0.04% |
| Jan. 24, 2025 | X4 Pharmaceuticals, Inc | $XFOR | Baldry Mark | Chief Commercial Officer | S | Common Stock | 29159 | $0.45 | 94,123.0000 | 201,062,211 | 23.65% | 0.01% |
| Oct. 4, 2024 | X4 Pharmaceuticals, Inc | $XFOR | Baldry Mark | Chief Commercial Officer | A | Common Stock | 34946 | $0.00 | 59,636.0000 | 6,695,509 | 141.54% | 0.52% |
| Oct. 7, 2024 | X4 Pharmaceuticals, Inc | $XFOR | Baldry Mark | Chief Commercial Officer | S | Common Stock | 11127 | $0.58 | 48,509.0000 | 6,695,509 | 18.66% | 0.17% |
| Feb. 13, 2024 | X4 Pharmaceuticals, Inc | $XFOR | Baldry Mark | Chief Commercial Officer | A | Stock Appreciation Right | 523414 | $0.00 | 523,414.0000 | 177,812,480 | 9999.99% | 0.29% |
| Nov. 1, 2023 | X4 Pharmaceuticals, Inc | $XFOR | Baldry Mark | Chief Commercial Officer | S | Common Stock | 10257 | $0.73 | 24,690.0000 | 63,525,845 | 29.35% | 0.02% |
| Oct. 31, 2023 | X4 Pharmaceuticals, Inc | $XFOR | Baldry Mark | Chief Commercial Officer | A | Common Stock | 34947 | $0.00 | 34,947.0000 | 63,525,845 | 9999.99% | 0.06% |